APA (7th ed.) Citation

Diya, O., Gayed, J., Lowry, F. S., Ma, H., Bangad, V., Mensa, F., . . . Gurtman, A. (2025). Safety and Immunogenicity of Monovalent Omicron KP.2-Adapted BNT162b2 COVID-19 Vaccine in Adults: Single-Arm Substudy from a Phase 2/3 Trial. Infectious Diseases & Therapy, 14(8), 1973. https://doi.org/10.1007/s40121-025-01185-4

Chicago Style (17th ed.) Citation

Diya, Oyeniyi, et al. "Safety and Immunogenicity of Monovalent Omicron KP.2-Adapted BNT162b2 COVID-19 Vaccine in Adults: Single-Arm Substudy from a Phase 2/3 Trial." Infectious Diseases & Therapy 14, no. 8 (2025): 1973. https://doi.org/10.1007/s40121-025-01185-4.

MLA (9th ed.) Citation

Diya, Oyeniyi, et al. "Safety and Immunogenicity of Monovalent Omicron KP.2-Adapted BNT162b2 COVID-19 Vaccine in Adults: Single-Arm Substudy from a Phase 2/3 Trial." Infectious Diseases & Therapy, vol. 14, no. 8, 2025, p. 1973, https://doi.org/10.1007/s40121-025-01185-4.